Histidylated nanovectors for mRNA vaccine formulation: Induction of a strong anti-tumor T cell immunity combined with inflammatory state

These last years, we are witnessing the emergence of new class of biopharmaceuticals based-on transcribed mRNA. They emerged as an extremely tunable vaccination platform. Formulations made of mRNA and liposomes (lipoplexes) have yielded strong T cell responses, but require induction of cytokines identical to those that have plagued clinical development of siRNA therapeutics. We have developed histidylated Lipid Polymer mRNA nanocomplexes (LPR) that combine the beneficial properties of lipid based and polymer based nanoparticles, including lowered cellular toxicities and improved colloidal stabilities. Immunization with LPR instigated extremely potent T-cell responses and showed superior effectiveness in controlling tumor growth compared to intravenous immunization with antigen mRNA electroporated dendrictic cells. Early innate responses to LPR were characterized by a type I IFN signature in the spleen. Nonetheless, conversely to LR, LPR did not depend on type I IFN responses to generate cytolytic effectors. This unique behavior of LPR enabled the generation of a less pro-inflammatory yet equally potent systemic LPR vaccine by usage of N1-methylpseudo-uridine (N1mψ) modified mRNA required to improve mRNA translatability by avoiding mRNA sensors activation. Overall, our data indicate that LPR can combine excellent immunogenicity with improved inflammatory and they could be an interesting alternative to formulations that are currently explored in early phase clinical trials.. Please click Additional Files below to see the full abstract

Nuclear delivery of NFκB-assisted DNA/polymer complexes: plasmid DNA quantitation by confocal laser scanning microscopy and evidence of nuclear polyplexes by FRET imaging

Quantification of a plasmid DNA (pDNA) and investigation of its polymer-associated state in the nucleus are crucial to evaluate the effectiveness of a gene-delivery system. This study was conducted with p3NF-luc-3NF, a pDNA-bearing optimized κB motif to favour NFκB-driven nuclear import. Here, a quantification of pDNA copies in the nucleus was performed by real-time confocal laser scanning microscopy in HeLa and C2C12 cells transfected with linear polyethylenimine or histidylated polylysine. Förster Resonance Energy Transfer (FRET) from the fluorescein-p3NF-luc-3NF donor to the co-localized rhodamine-polymer acceptor was carried out to investigate whether the pDNA was still condensed with the polymer in the nucleus. Upon 5 h of transfection, the nuclear amount of p3NF-luc3NF was ∼1500 copies in both cell lines whereas that of pTAL-luc, a 3NF-free counterpart pDNA, was less than 250. This quantity of p3NF-luc-3NF dropped dramatically to that of pTAL-luc in the presence of the BAY 11-7085, an inhibitor of NFκB activation. These data strongly support a nuclear import of p3NF-luc3NF mediated by NFκB. Moreover, FRET experiments clearly revealed that most of nuclear pDNA were still condensed with the polymer raising the question of their passage through the nuclear pore complex and their impact on the gene-expression efficiency

In Vivo bone tissue induction by freeze-dried collagen-nanohydroxyapatite matrix loaded with BMP2/NS1 mRNAs lipopolyplexes

Messenger RNA (mRNA) activated matrices (RAMs) are interesting to orchestrate tissue and organ regeneration due to the in-situ and sustained production of functional proteins. However, the immunogenicity of in vitro transcribed mRNA and the paucity of proper in vivo mRNA delivery vector need to be overcome to exert the therapeutic potential of RAM. We developed a dual mRNAs system for in vitro osteogenesis by co-delivering NS1 mRNA with BMP2 mRNA to inhibit RNA sensors and enhance BMP-2 expression. Next, we evaluated a lipopolyplex (LPR) formulation platform for in vivo mRNA delivery and adapted the LPRs for RAM preparation. The LPR formulated BMP2/NS1 mRNAs were incorporated into an optimized collagen-nanohydroxyapatite scaffold and freeze-dried to prepare ready-to-use RAMs. The loaded BMP2/NS1 mRNAs lipopolyplexes maintained their spherical morphology in the RAM, thanks to the core-shell structure of LPR. The mRNAs release from RAMs lasted for 16 days resulting in an enhanced prolonged transgene expression period compared to direct cell transfection. Once subcutaneously implanted in mice, the BMP2/NS1 mRNAs LPRs containing RAMs (RAM-BMP2/NS1) induced significant new bone tissue than those without NS1 mRNA, eight weeks post implantation. Overall, our results demonstrate that the BMP2/NS1 dual mRNAs system is suitable for osteogenic engagement, and the freeze-dried RAM-BMP2/NS1 could be promising off-the-shelf products for clinical orthopedic practice.info:eu-repo/semantics/publishedVersio

New histidylated cationic lipids for DNA and mRNA- based lipofection

Plasmid delivery into the cytosol remains one of the limiting factor to achieve efficient transfection. We have previously demonstrated that the presence of endosome-disrupting multiple histidine functionalities in the molecular architecture of cationic polymers significantly enhances their gene delivery efficiencies. We designed and synthesized two novel non-glycerol and a cholesterol based histidylated cationic amphiphiles containing a single histidine head group. Physico-chemical characteristics of all the novel liposomes and lipoplexes including lipid:DNA interactions, global surface charge, sizes, etc. were evaluated. We found that L-histidine-(N,N-di-n-hexadecylamine)ethylamide (lipid 1) and L-Histidine(N,N-di-n-hexadecylamine, N-methyl)ethylamide (lipid 2) in combination with cholesterol and Cholesteryl-L-Histidine-Ethylamide (lipid 3) in combinaison with DOPE gave efficient DNA and mRNA transfections into various cell lines. DNA transfection efficiency into A549, 293T7 and HeLa cells of Chol/lipid 1 lipoplexes was similar with that of FuGENE6 and DC-Chol lipoplexes but was two order of magnitude higher in HepG2 cells. Membrane fusion activity measurements using FRET technique showed that the histidine head-groups of Chol/lipid 1 liposomes mediated membrane fusion in the pH range 5-7. By using the cytosolic luciferase expression vector (pT7Luc) under the control of the bacterial T7 promoter, we showed that the release of DNA from the endosomally trapped lipoplexes to the cytosol is acidic dependent and presumably mediated by the imidazole ring protonation of histidine head group of these cationic amphiphiles. A better efficiency was obtained with Chol/lipid 2 lipoplexes than with Chol/lipid 1 lipoplexes when using the cytosolic luciferase expression vector. As anticipated, transfection efficiency of Lipid 3 was greatly inhibited in the presence of Bafilomycin A1. By contrast, endosome escape of DNA with a new cholesterol based cationic lipid containing no histidine head-group (Alanine-Cholesteryl-Ethylamide; lipid 4) seemed to be independent of endosome acidification. However, transfection efficacy of lipids 3 & 4 was similar. In conclusion, we show that covalent grafting of a single histidine amino acid residue to suitable twin-chain hydrophobic compounds or cholesterol is sufficient to impart remarkable transfection properties on the resulting cationic amphiphile via endosome-disrupting characteristics of the histidine functionalities Figure 1

Positively charged microbubbles to target nucleic acid delivery with ultrasound

Congrès sous l’égide de la Société Française de Génie Biologique et Médical (SFGBM).National audienceNucleic acid delivery in vivo via physical means or non-viral vectors still need improvements in particular to reach deep tissues. Sonoporation is highly advantageous for this purpose as ultrasound can be focalised to a particular tissue leading to targeted gene delivery, without alteration of the environing tissues. Few examples of transfection using cationic microbubbles (MBs) and DNA have been reported. We ought to improve the existing systems by developing positively charged MBs able to oscillate in order to follow their fate in vivo and gain in understanding of the pharmacokinetic of the MBs, then target DNA delivery with ultrasound. After optimisation, we obtained MBs in the 1-3 !m range (98% below 10 !m) able to adsorb nucleic acid on their surface. In vitro parameters have been optimised to obtain in vitro transfection both with DNA and siRNA. The systemic injection in mice led to the observation of these MBs in the liver in less than 10 seconds. This investigation allows to address the key parameters to tentatively obtain reproducible gene transfection in vivo

Mise au point de vecteurs non viraux pour la thérapie génique (étude du trafic intracellulaire de complexes ADN plasmidique/polylysines histidylées)

L'optimisation de vecteurs synthétiques pour le transfert de gènes et la thérapie génique nous a conduit à l'étude du trafic intracellulaire par cytométrie en flux et microscopie confocale de polyplexes (ADNp/polylysines histidylées et/ou glycosylées) dans les cellules humaines épithéliales des voies aériennes et d'hépatocarcinome. Après internalisation, l'ADNp et les polymères ségrègent dans des vésicules acides différentes : les polyplexes histidylés sont internalisés par endocytose indépendante de l'actine contrairement à ceux lactosylés. L'analyse immunologique de vésicules isolées contenant les polyplexes par cytométrie en flux indique que le plasmide s'accumule dans des vésicules peu acides (pH 6,4) non révélées par des marqueurs d'endocytose. Nous proposons ainsi un mode d'internalisation des polyplexes dans ces cellules. L'isolement et la caractérisation biochimique de ces vésicules permettraient la création de vecteurs plus performants pour le passage de l'ADNp dans le cytosol.In order to improve synthetic vectors efficiency for gene transfer and gene therapy, the intracellular traffiking of polyplexes (pDNA/ histidylated polylysine and/or glycosylated) was achieved by flow cytometry and confocal microscopy into human airway epithelial cells and human hepatocarcinoma cells. This study shows that polyplexes are rapidely dissociated upon internalization and then pDNA and polymers route in different acidic vesicles. We demonstrated that histidylated polyplexes were internalized by an endocytosis actin-independent process contrary to lactosylated polyplexes. A flow cytometry analysis of vesicles containing polyplexes indicate that the pDNA reaching less acidic vesicles (pH 6,4) are not labelled with the endocytotic markers. We propose a polyplexes internalization model in these cells. The isolation of these vesicles and their biochemical caracterization would help us to design more powerful vectors those increasing especially pDNA delivery into the cytosol.TOURS-BU Sciences Pharmacie (372612104) / SudocSudocFranceF

Efficient Gene Transfer by Histidylated Polylysine/pDNA Complexes

International audiencePlasmid/polylysine complexes, which are used to transfect mammalian cells, increase the uptake of DNA, but plasmid molecules are sequestered into vesicles where they cannot escape to reach the nuclear machinery. However, the transfection efficiency increases when membrane-disrupting reagents such as chloroquine or fusogenic peptides, are used to disrupt endosomal membranes and to favor the delivery of plasmid into the cytosol. We designed a cationic polymer that forms complexes with a plasmid DNA (pDNA) and mediates the transfection of various cell lines in the absence of chloroquine or fusogenic peptides. This polymer is a polylysine (average degree of polymerization of 190) partially substituted with histidyl residues which become cationic upon protonation of the imidazole groups at pH below 6.0. The transfection efficiency was optimal with a polylysine having 38 +/- 5% of the epsilon-amino groups substituted with histidyl residues; it was not significantly impaired in the presence of serum in the culture medium. The transfection was drastically inhibited in the presence of bafilomycin A1, indicating that the protonation of the imidazole groups in the endosome lumen might favor the delivery of pDNA into the cytosol

Transfert d'ARNm par des lipopolyplexes et vaccination antimélanome (ciblage des cellules dendritiques à l'aide de lipopolyplexes mannosylés)

Précédemment, il a été démontré au laboratoire qu une vaccination des souris avec des lipopolyplexes (LPR) contenant l ARNm de l antigène de mélanome MART1 permet d induire la formation de lymphocytes T cytotoxiques spécifiques et de retarder le développement de mélanomes B16F10 et de métastases pulmonaires. Les LPR sont des complexes ternaires constitués d ARNm, d un polymère cationique histidylé et de liposomes cationiques histidylés. L objectif de ma thèse était d améliorer cette vaccination antitumorale en développant de nouveaux liposomes capables de cibler les cellules dendritiques (DC). Le ciblage a été réalisé en incorporant un glycolipide mannosylé aux liposomes afin de favoriser leur reconnaissance par le récepteur mannose. A partir de ces liposomes, des formulations de complexes ternaires à base d ADN (LPD mannosylés ou Man11-LPD100) ou à base d ARN (LPR mannosylés ou Man11- LPR100) ont été mis au point. Les résultats montrent que : in vitro les formulations Man11-LPD100 sont mieux internalisés et transfectent plus efficacement les DC que les LPD100 non mannosylés. Les formulations Man11-LPR100 transfectent avec une plus grande efficacité les DC par rapport aux Man11- LPD100. Par ailleurs, une forte réduction de la toxicité des formulations a été obtenue en dialysant les liposomes. Il est également possible de conserver les formulations sous forme déshydratée. Une imagerie par scintigraphie effectuée chez la souris a permis de constater que 9% des LPD sont captés dans la rate après une injection IV. Nous avons mis en évidence après un isolement de DC spléniques que les formulations Man11-LPR100 transfectent 4 fois plus de DC que les LPR non manosylés. Enfin, l immunisation des souris avec Man11-LPR100 contenant l ARNm MART1 permet une vaccination plus efficace contre la tumeur B16F10 et une meilleure survie. En conclusion, les LPR Man11-LPD100 sont de bons vecteurs pour cibler et transfecter les DC spléniques avec l ARNm d un antigène tumoral et pour induire la réponse immune contre les cellules tumorales.Previously, it has been demonstrated that mice vaccination with lipopolyplexes (LPR) containing melanoma antigen MART1 mRNA can induce the generation of specific cytotoxic T cells and delay B16F10 melanoma growth and lung metastases. LPR are ternary complexes consisting of mRNA, a histidylated cationic polymer and histidylated cationic liposomes. The objective of my thesis was to enhance this antitumor vaccination through the development of new liposomes that can target specifically dendritic cells (DC). The targeting of DC was achieved by incorporating a mannosylated glycolipid within liposomes to enhance their recognition by the mannose receptor. From these liposomes, formulations based ternary complexes of DNA (mannosylated-LPD or Man11-LPD100) or formulations based on mRNA (mannosylated LPR or Man11 LPR100) were developed. The results show that formulations made with Man11-LPD100 are better internalized and transfect efficiently DC than LPD100. Man11 LPR100 transfect with greater efficiency DC compared to DNA based formulation (Man11-LPD100). Furthermore, a strong reduction of the toxicity of LPD was obtained by liposomes dialysis. It is also possible to preserve their activity by freeze-drying. Mice scintigraphy revealed that 9% of LPD are captured in the spleen following IV injection. We demonstrated after isolation of splenic DC that Man11-LPR100 transfect DC 4 times more than LPR100. Finally, immunization of mice with Man11-LPR100 containing mRNA MART1 allows a more effective vaccination against B16F10 tumor and a better mice survival than non-mannosylated ones. In conclusion, Man11-LPR100 are promising vectors to target and transfect splenic DC with a tumor antigen mRNA aiming to an induction of an immune response against tumor cells.ORLEANS-SCD-Bib. electronique (452349901) / SudocSudocFranceF

Lipid-based mRNA vaccine delivery systems

International audienceSynthetic mRNAs can become biopharmaceutics allowing vaccination against cancer, bacterial and virus infections. Clinical trials with direct administration of synthetic mRNAs encoding tumor antigens demonstrated safety and induction of tumor-specific immune responses. Although immune responses are generated by naked mRNAs, their formulations with chemical carriers are expected to provide more specificity and internalization in dendritic cells (DCs) for better immune responses and dose reduction. This review reports lipid-based formulations (LBFs) that have proved preclinical efficacy. The selective delivery of mRNA LBFs to favor intracellular accumulation in DCs and reduction of the effective doses is discussed, notably to decorate LBFs with carbohydrates or glycomimetics allowing endocytosis in DCs. We also report how smart intracellular delivery is achieved using pH-sensitive lipids or polymers for an efficient mRNA escape from endosomes and limitations regarding cytosolic mRNA location for translation

Mannosylated and Histidylated LPR Technology for Vaccination with Tumor Antigen mRNA

International audiencemRNA-based vaccines are currently being developed for treating various diseases including cancers. For this purpose, synthetic or in vitro transcribed (IVT) mRNA encoding tumor antigen offers several advantages over plasmid DNA encoding tumor antigen including better delivery and security. In this chapter, we report the preparation of mannosylated mRNA nanoparticles termed mannosylated lipopolyplexes or Man-LPR loaded with mRNA encoding a melanoma antigen. This formulation enhances the transfection of dendritic cells (DCs) in vivo and the anti-B16F10 melanoma vaccination in mice. The mRNA is formulated with histidylated liposomes and a histidylated polymer. Those pH-sensitive vectors promote membrane destabilization in endosomes upon the protonation of their histidine groups, allowing nucleic acid delivery in the cytosol. To favor DCs targeting via the mannose receptor, a mannose lipid is incorporated in the liposomes. Here, we provide protocols for the preparation of mannosylated liposomes, the synthesis of mRNA, mice immunization based on systemic injection, measurement of the cellular immune response and determination of the number of transfected splenic DC